Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byUS WorldMeds
Price$35.7M
Date8/2010

General Information

Websitesolsticeneuro.com
CategoryBioTech
Phone650-243-4400
Emailcontact@solsticen...
Employees

Offices

South San Francisco, USA
701 Gateway Boulevard
Suite 250
South San Francisco, CA, 94080
USA

Funding

Tags

Solstice Neurosciences

Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice’s first product named Myobloc® (rimabotulinumtoxinB) Injection in the U.S. and NeuroBloc® (Botulinum Toxin Type B) Injectable Solution in select overseas markets, represents the only botulinum toxin type B currently available to physicians and patients worldwide.

Recent Milestones

Videos

Screenshots

Solstice Neurosciences screenshot
Above: Solstice Neurosciences
Uploaded: 4/20/10

Sources

  1. US WorldMeds Acquires Solstice Neurosciences (usworldmeds.com) [edit]
  2. EDGAR [edit]
  3. Solstice Neurosciences Raises $85 Million in Private Financing (solsticeneuro.com) [edit]
Edit This Page
Last Edited 10/15/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy